KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hologic (HOLX) Research & Development (2016 - 2025)

Historic Research & Development for Hologic (HOLX) over the last 17 years, with Q4 2025 value amounting to $60.5 million.

  • Hologic's Research & Development rose 33.17% to $60.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $248.5 million, marking a year-over-year decrease of 668.42%. This contributed to the annual value of $248.2 million for FY2025, which is 901.76% down from last year.
  • Hologic's Research & Development amounted to $60.5 million in Q4 2025, which was up 33.17% from $65.1 million recorded in Q3 2025.
  • In the past 5 years, Hologic's Research & Development ranged from a high of $76.5 million in Q3 2021 and a low of $60.3 million during Q4 2024
  • Its 5-year average for Research & Development is $68.8 million, with a median of $69.2 million in 2021.
  • As far as peak fluctuations go, Hologic's Research & Development surged by 4503.04% in 2021, and later plummeted by 1756.03% in 2025.
  • Quarter analysis of 5 years shows Hologic's Research & Development stood at $72.8 million in 2021, then increased by 2.75% to $74.8 million in 2022, then fell by 10.7% to $66.8 million in 2023, then fell by 9.73% to $60.3 million in 2024, then rose by 0.33% to $60.5 million in 2025.
  • Its last three reported values are $60.5 million in Q4 2025, $65.1 million for Q3 2025, and $61.4 million during Q2 2025.